BBK Worldwide® Blog

Elizabeth Gargill

Recent Posts

HYBRID: A New Approach for Clinical Trial Recruitment & Engagement Success

Posted by Elizabeth Gargill on Mon, May 23, 2022

Introducing a New Approach to Clinical Trial Recruitment & Engagement

 

Our hybrid approach to clinical trial recruitment and engagement provides sponsors with the flexibility and agility they need whether they are conducting a traditional site-based trial, hybrid trial, or decentralized trial. 

Read More

Topics: TrialCentralNet, Decentralized Clinical Trials, Decentralized Solutions, Hybrid Clinical Trials, Hybrid, TCN

Facilitating the Journey from Patient to Study Participant

Posted by Elizabeth Gargill on Wed, Apr 27, 2022

Pharma15 Live!

Facilitating the Journey from Patient to Study Participant

The Impact of Dynamic Referral Processing

Matt Kibby and Aaron Fleishman return to the Pharma15 Live! stage to discuss BBK's dynamic referral processing service and how it improves and accelerates the patient enrollment process. 

"Our process benefits both patients and sites alike. It unburdens the study staff, creating a better experience for them, while also ensuring patients are responded to more quickly and with better care so their journey is a positive one."

-Matt Kibby, President, Chief Strategy Officer, BBK Worldwide

Watch Now

Read More

Topics: Pharma15 Live!, Call Centers, Matt Kibby, Aaron Fleishman, Hybrid Clinical Trials, Dynamic Referral Processing, Secondary Prescreening

Prioritizing the Patient Voice with Hybrid Clinical Trials

Posted by Elizabeth Gargill on Tue, Mar 8, 2022

 

New survey findings reveal the importance of offering patients choice when it comes to improving clinical trial diversity, access, and engagement.

Patients want options, or choice, when it comes to clinical trial participation. New data from a recent Study Voices survey reveals the impact choice can have on participation. The findings empower clinical trial sponsors to shift from traditional clinical trial models to hybrid models with confidence.

 

DOWNLOAD NOW

Read More

Topics: Most Viewed, Study Voices, Aaron Fleishman, International Clinical Trials, Surveys, Hybrid Clinical Trials

2022: A Look into Our Crystal Ball

Posted by Elizabeth Gargill on Wed, Jan 5, 2022

 

The clinical trial landscape saw a lot of changes in 2021, from decentralized clinical trial adoption to a greater emphasis on diversity and inclusion. But what’s in store for 2022? We asked our industry experts to weigh in with their predictions.

Read More

Topics: Most Viewed, Aaron Fleishman, Mike Johnson, Danielle Frate, Dena Raffa, 2022 Predictions, Justin Jones, Crystal Ball

Survey: Patients Want Choice Offered through Hybrid Clinical Trials

Posted by Elizabeth Gargill on Mon, Dec 20, 2021

New survey results and insights help clinical trial sponsors improve diversity and inclusion, enroll faster, and keep participants engaged longer.

When we developed our latest Study Voices survey, we expected to see large gaps in attitudes and experiences among healthcare consumers and clinical trial participants based on factors such as age, race, ethnicity, gender, and income – but that wasn’t the case.

Read More

Topics: Patient Engagement, Study Voices, Surveys, Diversity, Inclusion, Patients, Hybrid Clinical Trials, Whitepaper

Catch Up on Our Content for Clinical Trial Sponsors

Posted by Elizabeth Gargill on Tue, Dec 7, 2021

Catch Up on Our Content for Clinical Trial Sponsors

Now is the perfect time to catch up on our most popular content of 2021!

Featuring insights from industry thought leaders, our content provides clinical trial sponsors with knowledge and guidance to help navigate today’s challenging clinical trial enrollment and engagement landscape.

Read More

Topics: RSG Arrive, Diversity, Inclusion, Decentralized Clinical Trials, Lookbook, Creative Portfolio

Decentralized Clinical Trials

Posted by Elizabeth Gargill on Fri, Oct 29, 2021

The One Thing Every Sponsor Needs to Start a Decentralized Clinical Trial Off Right

I recently sat down with Chief Innovation Officer Rob Laurens to discuss how BBK's Engagement Solution Center solves many of the challenges sponsors face when planning and initiating a decentralized clinical trial. 

Read More

Topics: Rob Laurens, Engagement Solution Center, Decentralized Clinical Trials, Focus 5, Decentralized Solutions

Cellectar Biosciences Announces Partnership With BBK Worldwide

Posted by Elizabeth Gargill on Thu, Oct 28, 2021

 

Earlier this week, Cellectar Biosciences, a late-stage clinical biopharmaceutical company focused on the discovery and development of targeted drugs for the treatment of cancer, announced its partnership with BBK to provide concierge services for patients participating in its clinical studies. The services are designed to improve patients' and their caregivers' access to high-quality care and innovative treatments for their cancer.

Read More

Topics: Most Viewed, Concierge Services, Cellectar

Mike Johnson Discusses RSG Arrive Milestone With Outsourcing-Pharma

Posted by Elizabeth Gargill on Thu, Oct 21, 2021

 

Earlier this week, BBK's Senior Director of Patient Engagement Services Mike Johnson spoke with Outsourcing-Pharma to discuss the RSG® Arrive travel program and its recent milestone of 20,000 completed trips.

In this in-depth interview, Mike discusses what sets this program apart from others as he highlights the concierge specialists who are experienced in understanding all the ramifications of a request, as it relates not only to arranging a travel itinerary but also ensuring the itinerary supports patient health, safety, and compliance. In addition, Mike shares insight into the significance of the milestone for BBK as well as the industry at large. Click here to read the full article.

Read More

Topics: Patient Engagement, Patient Centricity, Patient Travel, Most Viewed, RSG Arrive, Mike Johnson, Outsourcing-Pharma, Engagement Solution Center, Concierge Services

Decentralized Clinical Trials: The Patient Perspective – Part 2

Posted by Elizabeth Gargill on Thu, Sep 30, 2021

 

Getting Decentralized Right

What Matters to Patients

In Part 2 of our two-part interview with Phil Kelly, we delve further into the patient perspective on decentralized clinical trials. We ask Phil Kelly to share his thoughts on patient needs, tools, technologies, and the patient experience.

If you are conducting a decentralized clinical trial or planning for one, this is a must-see segment, with valuable insight to leverage for success.

Watch Now

Read More

Topics: Patient, Pharma15 Live!, Most Viewed, Patient Voice, Patient Centric, Decentralized Clinical Trials, Phil Kelly